AAAAAA

   
Results: 1-18 |
Results: 18
INDIVIDUALIZING THERAPY TO PREVENT POSTMENOPAUSAL OSTEOPOROSIS - A COMPARISON OF HORMONE-THERAPY, ALENDRONATE, AND RALOXIFENE
Authors: COL NF PAUKER SG GOLDBERG RJ ECKMAN MH ORR RK ROSS EM WONG JB
Citation: Nf. Col et al., INDIVIDUALIZING THERAPY TO PREVENT POSTMENOPAUSAL OSTEOPOROSIS - A COMPARISON OF HORMONE-THERAPY, ALENDRONATE, AND RALOXIFENE, Medical decision making, 18(4), 1998, pp. 467-467
ANTITHROMBOTIC THERAPY IN VALVULAR HEART-DISEASE
Authors: SALEM DN LEVINE HJ PAUKER SG ECKMAN MH DAUDELIN DH
Citation: Dn. Salem et al., ANTITHROMBOTIC THERAPY IN VALVULAR HEART-DISEASE, Chest, 114(5), 1998, pp. 590-601
MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES
Authors: ECKMAN MH LEVINE HJ SALEM DN PAUKER SG
Citation: Mh. Eckman et al., MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES, Chest, 114(5), 1998, pp. 699-714
COST-EFFECTIVENESS OF THERAPIES FOR PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION
Authors: ECKMAN MH FALK RH PAUKER SG
Citation: Mh. Eckman et al., COST-EFFECTIVENESS OF THERAPIES FOR PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION, Archives of internal medicine, 158(15), 1998, pp. 1669-1677
FACILITATING PATIENT-SPECIFIC DECISIONS REGARDING HORMONE REPLACEMENTTHERAPY - REPLY
Authors: COL NF PAUKER SG ECKMAN MH WONG JB
Citation: Nf. Col et al., FACILITATING PATIENT-SPECIFIC DECISIONS REGARDING HORMONE REPLACEMENTTHERAPY - REPLY, JAMA, the journal of the American Medical Association, 278(6), 1997, pp. 476-476
PATIENT-SPECIFIC DECISIONS ABOUT HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN
Authors: COL NF ECKMAN MH KARAS RH PAUKER SG GOLDBERG RJ ROSS EM ORR RK WONG JB
Citation: Nf. Col et al., PATIENT-SPECIFIC DECISIONS ABOUT HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN, JAMA, the journal of the American Medical Association, 277(14), 1997, pp. 1140-1147
COST-EFFECTIVENESS OF ORAL AS COMPARED WITH INTRAVENOUS ANTIBIOTIC-THERAPY FOR PATIENTS WITH EARLY LYME-DISEASE OR LYME-ARTHRITIS
Authors: ECKMAN MH STEERE AC KALISH RA PAUKER SG
Citation: Mh. Eckman et al., COST-EFFECTIVENESS OF ORAL AS COMPARED WITH INTRAVENOUS ANTIBIOTIC-THERAPY FOR PATIENTS WITH EARLY LYME-DISEASE OR LYME-ARTHRITIS, The New England journal of medicine, 337(5), 1997, pp. 357-363
COST-EFFECTIVENESS OF NONINVASIVE TESTING FOR OSTEOMYELITIS - REPLY
Authors: ECKMAN MH WONG JB GREENFIELD S MACKEY WC PAUKER SG
Citation: Mh. Eckman et al., COST-EFFECTIVENESS OF NONINVASIVE TESTING FOR OSTEOMYELITIS - REPLY, JAMA, the journal of the American Medical Association, 274(13), 1995, pp. 1013-1014
FOOT INFECTIONS IN DIABETIC-PATIENTS - DECISION AND COST-EFFECTIVENESS ANALYSES
Authors: ECKMAN MH GREENFIELD S MACKEY WC WONG JB KAPLAN S SULLIVAN L DUKES K PAUKER SG
Citation: Mh. Eckman et al., FOOT INFECTIONS IN DIABETIC-PATIENTS - DECISION AND COST-EFFECTIVENESS ANALYSES, JAMA, the journal of the American Medical Association, 273(9), 1995, pp. 712-720
SCREENING FOR PROSTATE-CANCER - REPLY
Authors: KRAHN MD MAHONEY JE DETSKY AS TRACHTENBERG J ECKMAN MH PAUKER SG
Citation: Md. Krahn et al., SCREENING FOR PROSTATE-CANCER - REPLY, JAMA, the journal of the American Medical Association, 273(15), 1995, pp. 1175-1176
ANTITHROMBOTIC THERAPY IN VALVULAR HEART-DISEASE
Authors: LEVINE HJ PAUKER SC ECKMAN MH
Citation: Hj. Levine et al., ANTITHROMBOTIC THERAPY IN VALVULAR HEART-DISEASE, Chest, 108(4), 1995, pp. 360-370
MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES
Authors: ECKMAN MH LEVINE HJ PAUKER SG
Citation: Mh. Eckman et al., MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES, Chest, 108(4), 1995, pp. 457-470
CLINICAL IMPACT OF INACCURACIES IN ANTICOAGULATION MONITORING
Authors: ECKMAN MH PAUKER SG
Citation: Mh. Eckman et Sg. Pauker, CLINICAL IMPACT OF INACCURACIES IN ANTICOAGULATION MONITORING, Archives of internal medicine, 155(1), 1995, pp. 115-116
SCREENING FOR PROSTATE-CANCER - A DECISION-ANALYTIC VIEW
Authors: KRAHN MD MAHONEY JE ECKMAN MH TRACHTENBERG J PAUKER SG DETSKY AS
Citation: Md. Krahn et al., SCREENING FOR PROSTATE-CANCER - A DECISION-ANALYTIC VIEW, JAMA, the journal of the American Medical Association, 272(10), 1994, pp. 773-780
VARIATION IN THE PROTHROMBIN-TIME RATIO DURING ORAL ANTICOAGULATION -REPLY
Authors: ECKMAN MH LEVINE HJ PAUKER SG
Citation: Mh. Eckman et al., VARIATION IN THE PROTHROMBIN-TIME RATIO DURING ORAL ANTICOAGULATION -REPLY, The New England journal of medicine, 330(7), 1994, pp. 510-510
MANAGEMENT AND PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER-RELATED HYPERCOAGULABLE STATES - A RISKY BUSINESS
Authors: SARASIN FP ECKMAN MH
Citation: Fp. Sarasin et Mh. Eckman, MANAGEMENT AND PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER-RELATED HYPERCOAGULABLE STATES - A RISKY BUSINESS, Journal of general internal medicine, 8(9), 1993, pp. 476-486
INACCURACIES IN ESTIMATES OF LIFE EXPECTANCIES OF PATIENTS WITH BRONCHIAL-CANCER IN CLINICAL DECISION-MAKING
Authors: BENBASSAT J ZAJICEK G VANOORTMARSSEN GJ BENDOV I ECKMAN MH
Citation: J. Benbassat et al., INACCURACIES IN ESTIMATES OF LIFE EXPECTANCIES OF PATIENTS WITH BRONCHIAL-CANCER IN CLINICAL DECISION-MAKING, Medical decision making, 13(3), 1993, pp. 237-244
EFFECT OF LABORATORY VARIATION IN THE PROTHROMBIN-TIME RATIO ON THE RESULTS OF ORAL ANTICOAGULANT-THERAPY
Authors: ECKMAN MH LEVINE HJ PAUKER SG
Citation: Mh. Eckman et al., EFFECT OF LABORATORY VARIATION IN THE PROTHROMBIN-TIME RATIO ON THE RESULTS OF ORAL ANTICOAGULANT-THERAPY, The New England journal of medicine, 329(10), 1993, pp. 696-702
Risultati: 1-18 |